1. Home
  2. JBGS vs PLSE Comparison

JBGS vs PLSE Comparison

Compare JBGS & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JBGS
  • PLSE
  • Stock Information
  • Founded
  • JBGS 2016
  • PLSE 2014
  • Country
  • JBGS United States
  • PLSE United States
  • Employees
  • JBGS N/A
  • PLSE N/A
  • Industry
  • JBGS Real Estate Investment Trusts
  • PLSE Medical/Dental Instruments
  • Sector
  • JBGS Real Estate
  • PLSE Health Care
  • Exchange
  • JBGS Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • JBGS 1.3B
  • PLSE 1.1B
  • IPO Year
  • JBGS 2017
  • PLSE 2016
  • Fundamental
  • Price
  • JBGS $15.54
  • PLSE $19.58
  • Analyst Decision
  • JBGS Sell
  • PLSE
  • Analyst Count
  • JBGS 2
  • PLSE 0
  • Target Price
  • JBGS $16.00
  • PLSE N/A
  • AVG Volume (30 Days)
  • JBGS 531.1K
  • PLSE 137.8K
  • Earning Date
  • JBGS 02-18-2025
  • PLSE 10-30-2024
  • Dividend Yield
  • JBGS 4.52%
  • PLSE N/A
  • EPS Growth
  • JBGS N/A
  • PLSE N/A
  • EPS
  • JBGS N/A
  • PLSE N/A
  • Revenue
  • JBGS $567,034,000.00
  • PLSE N/A
  • Revenue This Year
  • JBGS N/A
  • PLSE N/A
  • Revenue Next Year
  • JBGS N/A
  • PLSE N/A
  • P/E Ratio
  • JBGS N/A
  • PLSE N/A
  • Revenue Growth
  • JBGS N/A
  • PLSE N/A
  • 52 Week Low
  • JBGS $13.65
  • PLSE $6.60
  • 52 Week High
  • JBGS $18.86
  • PLSE $22.69
  • Technical
  • Relative Strength Index (RSI)
  • JBGS 50.86
  • PLSE 58.17
  • Support Level
  • JBGS $14.11
  • PLSE $17.18
  • Resistance Level
  • JBGS $15.76
  • PLSE $18.72
  • Average True Range (ATR)
  • JBGS 0.38
  • PLSE 1.10
  • MACD
  • JBGS 0.09
  • PLSE 0.03
  • Stochastic Oscillator
  • JBGS 86.67
  • PLSE 79.66

About JBGS JBG SMITH Properties

JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in and develops real estate assets concentrated in urban infill submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to the legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily and third-party asset management and real estate services. The company generates majority of its revenue from Commercial segment.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: